Structure

Physi-Chem Properties

Molecular Weight:  384.12
Volume:  377.986
LogP:  2.927
LogD:  2.537
LogS:  -4.025
# Rotatable Bonds:  3
TPSA:  109.36
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.596
Synthetic Accessibility Score:  3.426
Fsp3:  0.286
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.809
MDCK Permeability:  1.538007018098142e-05
Pgp-inhibitor:  0.009
Pgp-substrate:  0.055
Human Intestinal Absorption (HIA):  0.019
20% Bioavailability (F20%):  0.015
30% Bioavailability (F30%):  0.522

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.015
Plasma Protein Binding (PPB):  97.10767364501953%
Volume Distribution (VD):  0.503
Pgp-substrate:  3.959064483642578%

ADMET: Metabolism

CYP1A2-inhibitor:  0.896
CYP1A2-substrate:  0.904
CYP2C19-inhibitor:  0.226
CYP2C19-substrate:  0.079
CYP2C9-inhibitor:  0.353
CYP2C9-substrate:  0.872
CYP2D6-inhibitor:  0.595
CYP2D6-substrate:  0.777
CYP3A4-inhibitor:  0.805
CYP3A4-substrate:  0.194

ADMET: Excretion

Clearance (CL):  9.37
Half-life (T1/2):  0.644

ADMET: Toxicity

hERG Blockers:  0.02
Human Hepatotoxicity (H-HT):  0.707
Drug-inuced Liver Injury (DILI):  0.9
AMES Toxicity:  0.05
Rat Oral Acute Toxicity:  0.064
Maximum Recommended Daily Dose:  0.408
Skin Sensitization:  0.369
Carcinogencity:  0.027
Eye Corrosion:  0.003
Eye Irritation:  0.024
Respiratory Toxicity:  0.041

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC103116

Natural Product ID:  NPC103116
Common Name*:   Licopyranocoumarin
IUPAC Name:   7-(2,4-dihydroxyphenyl)-2-(hydroxymethyl)-5-methoxy-2-methyl-3,4-dihydropyrano[3,2-g]chromen-8-one
Synonyms:   Licopyranocoumarin
Standard InCHIKey:  MOBCUWLJOZHPQL-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C21H20O7/c1-21(10-22)6-5-13-18(28-21)9-17-15(19(13)26-2)8-14(20(25)27-17)12-4-3-11(23)7-16(12)24/h3-4,7-9,22-24H,5-6,10H2,1-2H3
SMILES:  CC1(CCc2c(cc3c(cc(c4ccc(cc4O)O)c(=O)o3)c2OC)O1)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL597425
PubChem CID:   122851
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0004154] Hydroxyisoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota Leaves n.a. n.a. PMID[12713396]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. root n.a. PMID[16441081]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[16675659]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota roots n.a. n.a. PMID[20022509]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21123068]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21866899]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[22074222]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. root n.a. PMID[22074222]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[23325115]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota Roots n.a. n.a. PMID[23541646]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. rhizome n.a. PMID[23867078]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. root n.a. PMID[23867078]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[24479468]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota roots n.a. n.a. PMID[24957203]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[25445757]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[25744461]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[26841168]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[28140583]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[28522265]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[29641206]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[32196343]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[7381508]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7154 Glycyrrhiza uralensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO1698 Glycyrrhiza inflata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified Inhibition = 10.0 % PMID[490274]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC103116 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9648 High Similarity NPC295696
0.9366 High Similarity NPC310370
0.9366 High Similarity NPC183642
0.9241 High Similarity NPC71739
0.9231 High Similarity NPC195357
0.9231 High Similarity NPC170812
0.9231 High Similarity NPC152771
0.9161 High Similarity NPC71903
0.9161 High Similarity NPC312881
0.9097 High Similarity NPC287286
0.9091 High Similarity NPC151946
0.9091 High Similarity NPC279573
0.9091 High Similarity NPC211110
0.9073 High Similarity NPC7989
0.9073 High Similarity NPC223701
0.9073 High Similarity NPC469405
0.9073 High Similarity NPC472583
0.906 High Similarity NPC100818
0.9041 High Similarity NPC471824
0.9021 High Similarity NPC155963
0.9021 High Similarity NPC232246
0.9021 High Similarity NPC153818
0.9021 High Similarity NPC281014
0.9021 High Similarity NPC294456
0.9021 High Similarity NPC212124
0.9021 High Similarity NPC184861
0.9021 High Similarity NPC225106
0.9007 High Similarity NPC256141
0.898 High Similarity NPC469701
0.8951 High Similarity NPC224543
0.8951 High Similarity NPC26954
0.8951 High Similarity NPC188380
0.8951 High Similarity NPC78746
0.8951 High Similarity NPC38099
0.8944 High Similarity NPC131950
0.894 High Similarity NPC263384
0.894 High Similarity NPC472420
0.894 High Similarity NPC472422
0.894 High Similarity NPC471676
0.894 High Similarity NPC244577
0.8889 High Similarity NPC217706
0.8889 High Similarity NPC476169
0.8889 High Similarity NPC304207
0.8889 High Similarity NPC108937
0.8889 High Similarity NPC477530
0.8889 High Similarity NPC48579
0.8889 High Similarity NPC471069
0.8889 High Similarity NPC477958
0.8889 High Similarity NPC207809
0.8889 High Similarity NPC279218
0.8889 High Similarity NPC471068
0.8889 High Similarity NPC470681
0.8889 High Similarity NPC259710
0.8882 High Similarity NPC475790
0.8882 High Similarity NPC150123
0.8882 High Similarity NPC56232
0.8882 High Similarity NPC161881
0.8882 High Similarity NPC10807
0.8882 High Similarity NPC244583
0.8881 High Similarity NPC472525
0.8874 High Similarity NPC180351
0.8861 High Similarity NPC471823
0.8846 High Similarity NPC97812
0.8844 High Similarity NPC229916
0.8831 High Similarity NPC471787
0.8831 High Similarity NPC474609
0.8831 High Similarity NPC474738
0.8831 High Similarity NPC109967
0.8831 High Similarity NPC78554
0.8831 High Similarity NPC475797
0.8831 High Similarity NPC469936
0.8831 High Similarity NPC129053
0.8831 High Similarity NPC321372
0.8828 High Similarity NPC471070
0.8828 High Similarity NPC221046
0.8828 High Similarity NPC471072
0.8828 High Similarity NPC471071
0.8824 High Similarity NPC248793
0.8824 High Similarity NPC180301
0.8819 High Similarity NPC283019
0.8819 High Similarity NPC149320
0.8819 High Similarity NPC177281
0.8819 High Similarity NPC476455
0.8819 High Similarity NPC128529
0.8819 High Similarity NPC471630
0.8819 High Similarity NPC223616
0.8819 High Similarity NPC55615
0.8819 High Similarity NPC160727
0.8816 High Similarity NPC471677
0.8816 High Similarity NPC474021
0.8816 High Similarity NPC209846
0.8816 High Similarity NPC328740
0.8816 High Similarity NPC289774
0.8816 High Similarity NPC474023
0.8816 High Similarity NPC477897
0.8811 High Similarity NPC267412
0.8811 High Similarity NPC287182
0.8811 High Similarity NPC260265
0.8811 High Similarity NPC50896
0.8811 High Similarity NPC47163
0.8811 High Similarity NPC213173
0.8811 High Similarity NPC84894
0.8811 High Similarity NPC100986
0.8811 High Similarity NPC180716
0.8811 High Similarity NPC195343
0.8811 High Similarity NPC319859
0.8811 High Similarity NPC326600
0.8811 High Similarity NPC224475
0.8811 High Similarity NPC204353
0.8811 High Similarity NPC62366
0.8811 High Similarity NPC164269
0.8811 High Similarity NPC127888
0.8811 High Similarity NPC166672
0.8811 High Similarity NPC18804
0.8811 High Similarity NPC198381
0.8811 High Similarity NPC74655
0.8803 High Similarity NPC307289
0.88 High Similarity NPC14875
0.88 High Similarity NPC142863
0.88 High Similarity NPC140120
0.8782 High Similarity NPC24164
0.8782 High Similarity NPC471976
0.8776 High Similarity NPC184053
0.8766 High Similarity NPC304745
0.8766 High Similarity NPC111341
0.8758 High Similarity NPC476238
0.8758 High Similarity NPC285623
0.8758 High Similarity NPC171651
0.8758 High Similarity NPC243171
0.8758 High Similarity NPC327269
0.8758 High Similarity NPC474656
0.8758 High Similarity NPC31627
0.8758 High Similarity NPC210597
0.8758 High Similarity NPC35567
0.8758 High Similarity NPC473996
0.875 High Similarity NPC474735
0.875 High Similarity NPC29777
0.875 High Similarity NPC471625
0.875 High Similarity NPC124478
0.875 High Similarity NPC281241
0.875 High Similarity NPC471115
0.875 High Similarity NPC472424
0.875 High Similarity NPC177308
0.875 High Similarity NPC471909
0.875 High Similarity NPC86892
0.8742 High Similarity NPC266572
0.8742 High Similarity NPC6511
0.8742 High Similarity NPC13481
0.8742 High Similarity NPC207575
0.8741 High Similarity NPC296624
0.8741 High Similarity NPC133956
0.8741 High Similarity NPC167111
0.8741 High Similarity NPC92805
0.8741 High Similarity NPC207002
0.8741 High Similarity NPC31849
0.8741 High Similarity NPC318400
0.8741 High Similarity NPC471910
0.8733 High Similarity NPC87950
0.8733 High Similarity NPC471764
0.8733 High Similarity NPC476347
0.8726 High Similarity NPC3629
0.8725 High Similarity NPC85624
0.8725 High Similarity NPC226722
0.871 High Similarity NPC78492
0.871 High Similarity NPC208152
0.8707 High Similarity NPC155552
0.8701 High Similarity NPC268193
0.8701 High Similarity NPC112701
0.8701 High Similarity NPC109594
0.8701 High Similarity NPC100134
0.8701 High Similarity NPC311579
0.8701 High Similarity NPC293286
0.8701 High Similarity NPC326592
0.8701 High Similarity NPC209760
0.8701 High Similarity NPC236756
0.8699 High Similarity NPC278600
0.8699 High Similarity NPC144512
0.8699 High Similarity NPC137262
0.8699 High Similarity NPC35501
0.8699 High Similarity NPC37428
0.8699 High Similarity NPC47040
0.8693 High Similarity NPC319910
0.8693 High Similarity NPC278476
0.8693 High Similarity NPC472636
0.8693 High Similarity NPC262039
0.8693 High Similarity NPC471229
0.8693 High Similarity NPC471675
0.8693 High Similarity NPC472580
0.8693 High Similarity NPC262038
0.8693 High Similarity NPC474772
0.8693 High Similarity NPC474744
0.8693 High Similarity NPC254412
0.8693 High Similarity NPC472423
0.8684 High Similarity NPC89442
0.8684 High Similarity NPC19238
0.8684 High Similarity NPC5173
0.8684 High Similarity NPC472628
0.8684 High Similarity NPC164299
0.8684 High Similarity NPC164205
0.8684 High Similarity NPC104236

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC103116 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.875 High Similarity NPD4380 Phase 2
0.8654 High Similarity NPD7075 Discontinued
0.859 High Similarity NPD4868 Clinical (unspecified phase)
0.8581 High Similarity NPD7096 Clinical (unspecified phase)
0.8535 High Similarity NPD4381 Clinical (unspecified phase)
0.8523 High Similarity NPD3750 Approved
0.8516 High Similarity NPD6801 Discontinued
0.8483 Intermediate Similarity NPD5124 Phase 1
0.8483 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.8452 Intermediate Similarity NPD7411 Suspended
0.8421 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8405 Intermediate Similarity NPD5844 Phase 1
0.8354 Intermediate Similarity NPD7768 Phase 2
0.8344 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD5403 Approved
0.8301 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8291 Intermediate Similarity NPD5402 Approved
0.8276 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD6799 Approved
0.8228 Intermediate Similarity NPD7819 Suspended
0.8212 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8188 Intermediate Similarity NPD3748 Approved
0.8182 Intermediate Similarity NPD5401 Approved
0.8165 Intermediate Similarity NPD1934 Approved
0.8158 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD4628 Phase 3
0.8151 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8146 Intermediate Similarity NPD1549 Phase 2
0.8144 Intermediate Similarity NPD6559 Discontinued
0.8113 Intermediate Similarity NPD1465 Phase 2
0.8113 Intermediate Similarity NPD2801 Approved
0.811 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD1652 Phase 2
0.8084 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD3749 Approved
0.8067 Intermediate Similarity NPD1510 Phase 2
0.8063 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD3817 Phase 2
0.8056 Intermediate Similarity NPD2797 Approved
0.8038 Intermediate Similarity NPD6599 Discontinued
0.8028 Intermediate Similarity NPD422 Phase 1
0.8014 Intermediate Similarity NPD4908 Phase 1
0.8013 Intermediate Similarity NPD1551 Phase 2
0.8013 Intermediate Similarity NPD2935 Discontinued
0.8013 Intermediate Similarity NPD2796 Approved
0.8012 Intermediate Similarity NPD3818 Discontinued
0.8 Intermediate Similarity NPD6166 Phase 2
0.8 Intermediate Similarity NPD8455 Phase 2
0.8 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD7054 Approved
0.7962 Intermediate Similarity NPD920 Approved
0.7947 Intermediate Similarity NPD4308 Phase 3
0.7922 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD1613 Approved
0.7919 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD7472 Approved
0.7917 Intermediate Similarity NPD7074 Phase 3
0.7911 Intermediate Similarity NPD1653 Approved
0.7905 Intermediate Similarity NPD3268 Approved
0.7905 Intermediate Similarity NPD6798 Discontinued
0.7905 Intermediate Similarity NPD2313 Discontinued
0.7901 Intermediate Similarity NPD3882 Suspended
0.7885 Intermediate Similarity NPD1511 Approved
0.7879 Intermediate Similarity NPD6232 Discontinued
0.787 Intermediate Similarity NPD6797 Phase 2
0.7866 Intermediate Similarity NPD5494 Approved
0.7862 Intermediate Similarity NPD3225 Approved
0.7834 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD2799 Discontinued
0.7829 Intermediate Similarity NPD7033 Discontinued
0.7824 Intermediate Similarity NPD7251 Discontinued
0.78 Intermediate Similarity NPD1240 Approved
0.7792 Intermediate Similarity NPD2424 Discontinued
0.7785 Intermediate Similarity NPD1512 Approved
0.7778 Intermediate Similarity NPD1610 Phase 2
0.7778 Intermediate Similarity NPD7808 Phase 3
0.777 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD6355 Discontinued
0.7746 Intermediate Similarity NPD1548 Phase 1
0.7742 Intermediate Similarity NPD1243 Approved
0.7738 Intermediate Similarity NPD7473 Discontinued
0.7733 Intermediate Similarity NPD6233 Phase 2
0.7722 Intermediate Similarity NPD2534 Approved
0.7722 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD2532 Approved
0.7722 Intermediate Similarity NPD2533 Approved
0.7716 Intermediate Similarity NPD37 Approved
0.7711 Intermediate Similarity NPD6959 Discontinued
0.7707 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD1607 Approved
0.7697 Intermediate Similarity NPD6234 Discontinued
0.7692 Intermediate Similarity NPD7228 Approved
0.7687 Intermediate Similarity NPD1203 Approved
0.7683 Intermediate Similarity NPD4967 Phase 2
0.7683 Intermediate Similarity NPD4966 Approved
0.7683 Intermediate Similarity NPD4965 Approved
0.7682 Intermediate Similarity NPD4060 Phase 1
0.7682 Intermediate Similarity NPD4307 Phase 2
0.7677 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD1296 Phase 2
0.7661 Intermediate Similarity NPD5953 Discontinued
0.7651 Intermediate Similarity NPD6832 Phase 2
0.7647 Intermediate Similarity NPD7286 Phase 2
0.7647 Intermediate Similarity NPD7097 Phase 1
0.7643 Intermediate Similarity NPD6190 Approved
0.764 Intermediate Similarity NPD3226 Approved
0.7632 Intermediate Similarity NPD230 Phase 1
0.763 Intermediate Similarity NPD8312 Approved
0.763 Intermediate Similarity NPD8313 Approved
0.7627 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD4288 Approved
0.7622 Intermediate Similarity NPD7585 Approved
0.7613 Intermediate Similarity NPD2346 Discontinued
0.7605 Intermediate Similarity NPD7199 Phase 2
0.76 Intermediate Similarity NPD4625 Phase 3
0.76 Intermediate Similarity NPD3027 Phase 3
0.759 Intermediate Similarity NPD919 Approved
0.7588 Intermediate Similarity NPD3751 Discontinued
0.7568 Intermediate Similarity NPD7583 Approved
0.7568 Intermediate Similarity NPD3266 Approved
0.7568 Intermediate Similarity NPD3267 Approved
0.756 Intermediate Similarity NPD7229 Phase 3
0.7556 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD3764 Approved
0.7548 Intermediate Similarity NPD6100 Approved
0.7548 Intermediate Similarity NPD6099 Approved
0.7543 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD7458 Discontinued
0.7516 Intermediate Similarity NPD447 Suspended
0.7516 Intermediate Similarity NPD2800 Approved
0.75 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6005 Phase 3
0.75 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6002 Phase 3
0.75 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6004 Phase 3
0.7483 Intermediate Similarity NPD9717 Approved
0.7471 Intermediate Similarity NPD7549 Discontinued
0.7468 Intermediate Similarity NPD7003 Approved
0.7456 Intermediate Similarity NPD3787 Discontinued
0.7453 Intermediate Similarity NPD6273 Approved
0.7453 Intermediate Similarity NPD5049 Phase 3
0.7438 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD4477 Approved
0.7436 Intermediate Similarity NPD4476 Approved
0.7434 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD7685 Pre-registration
0.7412 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD1933 Approved
0.7403 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4340 Discontinued
0.7396 Intermediate Similarity NPD8127 Discontinued
0.7389 Intermediate Similarity NPD7266 Discontinued
0.7386 Intermediate Similarity NPD4062 Phase 3
0.738 Intermediate Similarity NPD7584 Approved
0.7371 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7095 Approved
0.7365 Intermediate Similarity NPD1608 Approved
0.7365 Intermediate Similarity NPD1481 Phase 2
0.7321 Intermediate Similarity NPD6971 Discontinued
0.7318 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD4749 Approved
0.7314 Intermediate Similarity NPD7240 Approved
0.7308 Intermediate Similarity NPD4536 Approved
0.7308 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD4538 Approved
0.7303 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD8434 Phase 2
0.7297 Intermediate Similarity NPD1535 Discovery
0.7297 Intermediate Similarity NPD1091 Approved
0.7296 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD1247 Approved
0.7284 Intermediate Similarity NPD7447 Phase 1
0.7267 Intermediate Similarity NPD5058 Phase 3
0.7267 Intermediate Similarity NPD8651 Approved
0.7267 Intermediate Similarity NPD6666 Approved
0.7267 Intermediate Similarity NPD6667 Approved
0.726 Intermediate Similarity NPD9545 Approved
0.726 Intermediate Similarity NPD1894 Discontinued
0.7253 Intermediate Similarity NPD4363 Phase 3
0.7253 Intermediate Similarity NPD4360 Phase 2
0.7251 Intermediate Similarity NPD5711 Approved
0.7251 Intermediate Similarity NPD5710 Approved
0.7237 Intermediate Similarity NPD2861 Phase 2
0.7225 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7783 Phase 2
0.7222 Intermediate Similarity NPD7212 Phase 2
0.7222 Intermediate Similarity NPD7213 Phase 3
0.7219 Intermediate Similarity NPD7435 Discontinued
0.7212 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD8150 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data